Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients
Key facts
- Where
- Sohag, EgyptSee the site
Where in Egypt
- Sohag UniversitySohag, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sohag University
- Trial code
- NCT07154186
- Record updated
- 5 September 2025
- Original description
This study aims to evaluate the impact of the triglyceride-glucose (TyG) index on the angiographic profiling of non-diabetic patients with premature coronary artery disease (CAD).Read full original descriptionShow less
Impact of Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients
This study aims to evaluate the impact of the triglyceride-glucose (TyG) index on the angiographic profiling of non-diabetic patients with premature coronary artery disease (CAD).
Inclusion: Age ≥18 years old; Both sexes; Non-diabetic patients [no history of diabetes, hemoglobin A1C (HbA1C) < 6.5%, fasting glucose < 126 mg/dL]; Confirmed diagnosis of coronary artery disease (CAD) by coronary angiography.
Exclusion: Previous history of coronary revascularization; Current use of triglyceride-lowering medications; Known diabetes mellitus (type 1 or type 2); Malignant disease, autoimmune disease, or systemic inflammatory disorders; Severe hepatic or renal dysfunction [alanine transaminase (ALT)/aspartate aminotransferase (AST) ≥ 5× upper limit of normal (ULN), estimated glomerular filtration rate (eGFR)< 30 mL/min/1.73 m²].